NCT01347866 2018-10-29Clinical Study Of PI3K/mTOR Inhibitors In Combination With An Oral MEK Inhibitor Or Irinotecan In Patients With Advanced CancerPfizerPhase 1 Terminated105 enrolled 64 charts
NCT00708773 2017-01-04Genotype-Directed Dose-Escalation Study of Irinotecan in Patients With Advanced Solid TumorsUniversity of ChicagoPhase 1 Completed68 enrolled